Novartis’s JAK Inhibitor Fails In COVID, Raising Questions On Lilly Prospects

Adds To Puzzle Over JAK Inhibitors

 
• By Andrew McConaghie
  
Covid19_Hospital_Room
The search goes on for therapies which can prevent deaths in people with severe COVID-19.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip